Cytological profiling: Providing more haystacks for chemists' needles

Genome Biology

Volumn 6, Issue 8, 2005, Pages

  Lorang, Janet ^a   King, Randall W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; ENZYME INHIBITOR; PROTEIN INHIBITOR; PROTEIN KINASE INHIBITOR;

AFFINITY CHROMATOGRAPHY; CARDIOTOXICITY; CELL ASSAY; CELL STRUCTURE; CELL TYPE; CYTOLOGY; DRUG POTENTIATION; DRUG PURIFICATION; DRUG SCREENING; DRUG TARGETING; ENZYME INHIBITION; HIGH THROUGHPUT SCREENING; HUMAN; SHORT SURVEY; STRUCTURE ANALYSIS;

CELL SHAPE; CELLS; CHROMATOGRAPHY, AFFINITY; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG EVALUATION, PRECLINICAL;

EID: 23944450123     PISSN: 14656906     EISSN: None     Source Type: Journal    
DOI: 10.1186/gb-2005-6-8-228     Document Type: Short Survey

References (11)

1. Frank-Kamenetsky M, Zhang XM, Bottega S, Guicherit O, Wichterle H, Dudek H, Bumcrot D, Wang FY, Jones S, Shulok J, et al.: Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists. J Biol 2002, 1 :10.
2. Tanaka M, Bateman R, Rauh D, Vaisberg E, Ramachandani S, Zhang C, Hansen KC, Burlingame AL, Trautman JK, Shokat KM, et al.: An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol 2005, 3:128.
3. Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, Altschuler SJ: Multidimensional drug profiling by automated microscopy. Science 2004, 306:1194-1198.
4. Berger AB, Vitorino PM, Bogyo M: Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery. Am J Pharmacogenomics 2004, 4:371-381.
5. Butcher RA, Schreiber SL: Using genome-wide transcriptional profiling to elucidate small-molecule mechanism. Curr Opin Chem Biol 2005, 9:25-30.
6. Fleming JA, Lightcap ES, Sadis S, Thoroddsen V, Bulawa CE, Blackman RK: Complementary whole-genome technologies reveal the cellular response to proteasome inhibition by PS-341. Proc Natl Acad Sci USA 2002, 99:1461-1466.
7. Giaever G, Flaherty P, Kumm J, Proctor M, Nislow C, Jaramillo DF, Chu AM, Jordan MI, Arkin AP, Davis RW: Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci USA 2004, 101:793-798.
8. Gunther EC, Stone DJ, Gerwien RW, Bento P, Heyes MP: Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci USA 2003, 100:9608-9613.
9. Kim YK, Arai MA, Arai T, Lamenzo JO, Dean EF III, Patterson N, Clemons PA, Schreiber SL: Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space. J Am Chem Soc 2004, 126:14740-14745.
10. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, et al.: An information-intensive approach to the molecular pharmacology of cancer. Science 1997, 275:343-349.
11. Burke MD, Schreiber SL: A planning strategy for diversity-oriented synthesis. Angew Chem Int Ed Engl 2004, 43:46-58.